SELLAS Life Sciences Group, Inc. (SLS) Tops Q3 EPS by 3c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Dell Technologies (DELL) call put ratio 1 call to 1 put with a focus on expiring August options
• Western Digital (WDC) call put ratio 1 call to 1 put as share price down 1.3%